Now Is the Time to Use 18F-FDG PET/CT to Optimize Neoadjuvant Treatment in Triple-Negative Breast Cancer!

被引：2
|
作者：
Groheux, David [1 ,2 ]
机构：
[1] St Louis Hosp, Dept Nucl Med, Paris, France
[2] Univ Paris Diderot, INSERM, CNRS, UMR944 7212, Paris, France
来源：
JOURNAL OF NUCLEAR MEDICINE | 2018年 / 59卷 / 06期
关键词：
PATHOLOGICAL COMPLETE RESPONSE; CHEMOTHERAPY; CARBOPLATIN; BEVACIZUMAB; METAANALYSIS;
D O I：
10.2967/jnumed.118.210922
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：863 / 864
页数：2
相关论文
共 50 条
  • [31] 18F-FDG PET Imaging For Monitoring The Early Anti-tumor Effect Of Albendazole On Triple-negative Breast Cancer
    Liu, H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S667 - S667
  • [32] 18F-FDG PET imaging for monitoring the early anti-tumor effect of albendazole on triple-negative breast cancer
    Liu, Honglian
    Sun, Hao
    Zhang, Bin
    Liu, Shengli
    Deng, Shengming
    Weng, Zhen
    Zuo, Bin
    Yang, Jianfeng
    He, Yang
    [J]. BREAST CANCER, 2020, 27 (03) : 372 - 380
  • [33] Combined use of 18F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy
    Pengel, Kenneth E.
    Koolen, Bas B.
    Loo, Claudette E.
    Vogel, Wouter V.
    Wesseling, Jelle
    Lips, Esther H.
    Rutgers, Emiel J. Th.
    Olmos, Renato A. Valdes
    Peeters, Marie Jeanne T. F. D. Vrancken
    Rodenhuis, Sjoerd
    Gilhuijs, Kenneth G. A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (08) : 1515 - 1524
  • [34] Combined use of 18F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy
    Kenneth E. Pengel
    Bas B. Koolen
    Claudette E. Loo
    Wouter V. Vogel
    Jelle Wesseling
    Esther H. Lips
    Emiel J. Th. Rutgers
    Renato A. Valdés Olmos
    Marie Jeanne T. F. D. Vrancken Peeters
    Sjoerd Rodenhuis
    Kenneth G. A. Gilhuijs
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1515 - 1524
  • [35] 18F-FDG PET imaging for monitoring the early anti-tumor effect of albendazole on triple-negative breast cancer
    Honglian Liu
    Hao Sun
    Bin Zhang
    Shengli Liu
    Shengming Deng
    Zhen Weng
    Bin Zuo
    Jianfeng Yang
    Yang He
    [J]. Breast Cancer, 2020, 27 : 372 - 380
  • [36] 18F-FDG PET Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer
    Humbert, Olivier
    Riedinger, Jean-Marc
    Vrigneaud, Jean-Marc
    Kanoun, Salim
    Dygai-Cochet, Inna
    Berriolo-Riedinger, Alina
    Toubeau, Michel
    Depardon, Edouard
    Lassere, Maud
    Tisserand, Simon
    Fumoleau, Pierre
    Brunotte, Francois
    Cochet, Alexandre
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (11) : 1707 - 1712
  • [37] Evaluation of prognostic risk factors of triple-negative breast cancer with 18F-FDG PET/CT parameters, clinical pathological features and biochemical indicators
    Zhu, Lei
    Yang, Xin
    Zhang, Jiying
    Wang, Shuling
    Wang, Yulong
    Wan, Xing
    Zhu, Xiang
    Song, Xiuyu
    Tong, Zhongsheng
    Yang, Meng
    Zhao, Weipeng
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [38] Prognostic Role of Early and End-of-Neoadjuvant Treatment 18F-FDG PET/CT in Patients With Breast Cancer
    Garcia Vicente, Ana Maria
    Amo-Salas, Mariano
    Relea Calatayud, Fernanda
    Munoz Sanchez, Maria del Mar
    Pena Pardo, Francisco Jose
    Jimenez Londono, German Andres
    Alvarez Cabellos, Ruth
    Espinosa Aunion, Ruth
    Soriano Castrejon, Angel
    [J]. CLINICAL NUCLEAR MEDICINE, 2016, 41 (07) : E313 - E322
  • [39] The Role of 18F-FDG PET/CT in Predicting the Neoadjuvant Treatment Response in Patients with Locally Advanced Breast Cancer
    Goktas Aydin, Sabin
    Bilici, Ahmet
    Olmez, Omer Fatih
    Oven, Basak B. B.
    Acikgoz, Ozgur
    Cakir, Tansel
    Basim, Pelin
    Cakir, Asli
    Kutlu, Yasin
    Hamdard, Jamshid
    [J]. BREAST CARE, 2022, 17 (05) : 470 - 479
  • [40] Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
    Humbert, Olivier
    Riedinger, Jean-Marc
    Charon-Barra, Celine
    Berriolo-Riedinger, Alina
    Desmoulins, Isabelle
    Lorgis, Veronique
    Kanoun, Salim
    Coutant, Charles
    Fumoleau, Pierre
    Cochet, Alexandre
    Brunotte, Francois
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (24) : 5460 - 5468
12345